Orphan Drugs and Rare Diseases Global Congress 2020 Europe

This conference brings together stakeholders in the orphan drugs industry to discuss and network with top tier government, pharmaceuticals, biotechs, non-profit organisations, orphan drug developers, research organisations as well as patients groups and advocates.

Dr Jonathan Appleby, Chief Scientific Officer

Panel - Cell and Gene Therapies for Rare Diseases

Time and date TBC

Find out more here

Discover who we are